Emerging Molecular Signaling Pathways and Therapeutic Targets for Urological Cancer

Dear Colleagues, 

Targeted therapies remain a significant need in prostate cancer; identifying and characterizing such pathways are critical for better overcoming resistance to current therapies. This Special Issue aims to focus on characterizing novel potential pathways for therapeutic targeting in urological cancers. The Special Issue will focus on review and new research topics related to defining biomarkers from which we can infer therapy resistance/response, the association of potential biomarkers with specific pathways related to disease progression, and possible potential targeted therapies. The submitted papers can span preclinical models, translation therapies, and clinical trials related to novel biomarkers or new pathways that can be targeted in any urological cancer.

Prof. Dr. Tarek A. Bismar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• biomarkers
• genomics
• targeted therapies
• disease progression
• cancer metastasis and signaling pathways